Calumet director exercises 7,067 RSUs into stock

Calumet, Inc. director Amy M. Schumacher reported the exercise and conversion of 7,067 Restricted Stock Units into an equal number of shares of common stock, par value $0.01 per share, on July 9, 2026.

Rhea-AI Filing Summary

Calumet, Inc. director Amy M. Schumacher reported the exercise and conversion of 7,067 Restricted Stock Units into an equal number of shares of common stock, par value $0.01 per share, on July 9, 2026. Each Restricted Stock Unit was the economic equivalent of one share of common stock, and 100% of these units vested on June 2, 2026. Following the transaction, Schumacher directly holds 258,160 shares of Calumet, Inc. common stock. The filing does not report any open-market purchases or sales, only the derivative exercise and corresponding share issuance.

Insider Trade Summary

7,067 shares exercised/converted

Exercise 2 txns

Insider Schumacher Amy M

Role Director

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Unit F1, F2	7,067	$0.00	$0.00
Exercise	Common Stock, par value $0.01 per share	7,067	$0.00	$0.00

Holdings After Transaction: Restricted Stock Unit — 0 contracts (Direct); Common Stock, par value $0.01 per share — 258,160 shares (Direct)

Footnotes (2)

1. F1. Each Restricted Stock Unit is the economic equivalent of one share of Calumet, Inc. common stock, par value $0.01 per share.
2. F2. 100% of the Restricted Stock Units vested on June 2, 2026.

Key Figures

RSUs Exercised: 7,067 units Common Shares After Transaction: 258,160 shares Vesting Date: June 2, 2026 +2 more

5 metrics

RSUs Exercised 7,067 units Restricted Stock Units converted into common stock on July 9, 2026

Common Shares After Transaction 258,160 shares Direct holdings of Calumet, Inc. common stock following the exercise

Vesting Date June 2, 2026 100% of the Restricted Stock Units vested on this date

Par Value $0.01 per share Par value of Calumet, Inc. common stock received upon RSU conversion

Exercise Count 1 exercise Single derivative exercise/conversion event in the transactionSummary

Key Terms

Restricted Stock Unit, economic equivalent, derivative exercise/conversion, par value

4 terms

Restricted Stock Unit financial

"The security title is listed as "Restricted Stock Unit" for the derivative"

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

economic equivalent financial

"Each Restricted Stock Unit is the economic equivalent of one share"

derivative exercise/conversion financial

"The transaction_action is described as derivative exercise/conversion"

par value financial

"Common Stock, par value $0.01 per share is received"

Par value is the fixed amount printed on a bond or stock that represents its original value when issued. It’s like the face value of a coin or bill—what the issuer promises to pay back or the starting price of a stock—though it often doesn’t change with market prices. It matters because it helps determine certain financial details, like how much the company will pay back at maturity.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Calumet, Inc. (CLMT) director Amy M. Schumacher report in this Form 4?

Amy M. Schumacher reported exercising 7,067 Restricted Stock Units into Calumet, Inc. common stock on July 9, 2026. The transaction reflects a derivative exercise/conversion, with no open-market purchases or sales disclosed in this filing.

How many Calumet, Inc. (CLMT) shares does Amy M. Schumacher hold after the reported transaction?

After the reported exercise, Amy M. Schumacher directly holds 258,160 shares of Calumet, Inc. common stock. This total reflects the addition of 7,067 shares received upon conversion of vested Restricted Stock Units into common stock.

What type of securities did Amy M. Schumacher convert in the Calumet, Inc. (CLMT) Form 4?

She converted 7,067 Restricted Stock Units, each described as the economic equivalent of one share of Calumet, Inc. common stock. These derivative securities were exchanged for an equal number of common shares in a derivative exercise/conversion transaction.

When did the Restricted Stock Units reported by Calumet, Inc. (CLMT) fully vest?

The filing states that 100% of the Restricted Stock Units vested on June 2, 2026. After vesting, 7,067 units were subsequently exercised and converted into an equal number of shares of Calumet, Inc. common stock.

Does the Calumet, Inc. (CLMT) Form 4 show any open-market buying or selling by Amy M. Schumacher?

No. The Form 4 reports no open-market purchases or sales. It only shows a derivative exercise/conversion of 7,067 Restricted Stock Units into common stock, with no tax withholding or gift transactions disclosed.

How is the transaction in Calumet, Inc. (CLMT) classified in the Form 4 summary?

The transaction is classified as a derivative exercise/conversion with transaction code “M,” counted as one exercise involving 7,067 shares. The transactionSummary shows acquire-side activity only, with net buy/sell direction described as neutral.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/13/2026 - 04:05 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Schumacher Amy M

(Last) (First) (Middle)

1060 N CAPITOL AVE

SUITE 6-401

(Street)

INDIANAPOLIS INDIANA 46204

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Calumet, Inc. /DE [ CLMT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.01 per share	07/09/2026		M		7,067	A	$0	258,160	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	07/09/2026		M			7,067	(2)	(2)	Common Stock, par value $0.01 per share	7,067	$0	0	D

Explanation of Responses:

1. Each Restricted Stock Unit is the economic equivalent of one share of Calumet, Inc. common stock, par value $0.01 per share.

2. 100% of the Restricted Stock Units vested on June 2, 2026.

Remarks:

	/s/ Connor J. Egan, as attorney-in-fact	07/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)